Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Sweeney

Showing results (61-70 of 264) with videos related to

Pageof 27
Sort By:
European Urology Oncology|August 15, 2019
Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with ProstatectomyAnis A Hamid, Kathryn P Gray, Ying Huang, et al.
Endocrine-Related Cancer|September 6, 2023
IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancerPraful Ravi, Victoria Wang, Raina N Fichorova, et al.
AJR. American Journal of Roentgenology|September 24, 2014
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumorStephanie A Howard, Kathryn P Gray, Elizabeth K O'Donnell, et al.
Molecular Cancer Therapeutics|April 14, 2005
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cellsMichele T Yip-Schneider, Harikrishna Nakshatri, Christopher J Sweeney, et al.
European Urology Focus|July 30, 2017
Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended ChemotherapyRowan E Miller, Sarah C Markt, Elizabeth O'Donnell, et al.
Clinical Genitourinary Cancer|October 13, 2018
Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern EraAnis A Hamid, Sarah C Markt, Cécile Vicier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2015
Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer ActivityXiaodong Wang, Ying Huang, Amanda Christie, et al.
Prostate Cancer and Prostatic Diseases|May 19, 2021
Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancerDaniel E Lage, M Dror Michaelson, Richard J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group studyJinxing Li, Beth Juliar, Constantin Yiannoutsos, et al.
Investigational New Drugs|May 4, 2004
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancerEardie A Curry, Daryl J Murry, Christy Yoder, et al.
Pageof 27

Showing results (61-70 of 264) with videos related to

Sort By:
Pageof 27
European Urology Oncology|August 15, 2019
Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with ProstatectomyAnis A Hamid, Kathryn P Gray, Ying Huang, et al.
Endocrine-Related Cancer|September 6, 2023
IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancerPraful Ravi, Victoria Wang, Raina N Fichorova, et al.
AJR. American Journal of Roentgenology|September 24, 2014
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumorStephanie A Howard, Kathryn P Gray, Elizabeth K O'Donnell, et al.
Molecular Cancer Therapeutics|April 14, 2005
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cellsMichele T Yip-Schneider, Harikrishna Nakshatri, Christopher J Sweeney, et al.
European Urology Focus|July 30, 2017
Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended ChemotherapyRowan E Miller, Sarah C Markt, Elizabeth O'Donnell, et al.
Clinical Genitourinary Cancer|October 13, 2018
Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern EraAnis A Hamid, Sarah C Markt, Cécile Vicier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2015
Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer ActivityXiaodong Wang, Ying Huang, Amanda Christie, et al.
Prostate Cancer and Prostatic Diseases|May 19, 2021
Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancerDaniel E Lage, M Dror Michaelson, Richard J Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a phase II Hoosier Oncology Group studyJinxing Li, Beth Juliar, Constantin Yiannoutsos, et al.
Investigational New Drugs|May 4, 2004
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancerEardie A Curry, Daryl J Murry, Christy Yoder, et al.
Pageof 27